Cited by 37Adrenal Hormones and DisordersPancreatic function and diabetesStress Responses and Cortisol

New directions for the treatment of adrenal insufficiency

Open access
Ruiz-Babot, Gerard, Hadjidemetriou, Irene, King, Peter James, Guasti, Leonardo·2015·Frontiers in Endocrinology

Abstract

Adrenal disease, whether primary, caused by defects in the hypothalamic-pituitary-adrenal (HPA) axis, or secondary, caused by defects outside the HPA axis, usually results in adrenal insufficiency, which requires lifelong daily replacement of corticosteroids. However, this kind of therapy is far from ideal as physiological demand for steroids varies considerably throughout the day and increases during periods of stress. The development of alternative curative strategies is therefore needed. In this review, we describe the latest technologies aimed at either isolating or generating de novo cells that could be used for novel, regenerative medicine application in the adrenocortical field.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fendo.2015.00070

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ESC- and iPSC-derived pancreatic beta cells have been used as an example of cell therapy for potential treatment of type 1 diabetes.

    “An example of cell therapy used ESCs-and iPSCs-derived pancreatic beta cells for potential treatment for type 1 diabetes (512).”

    From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [512]

    The “Stem Cells and Reprograming Strategies” section describes efforts to generate pancreatic beta cells to treat type 1 diabetes and a planned clinical evaluation of stem-cell-derived islet replacement therapy. It does not specify that the pancreatic beta cells were derived from both ESCs and iPSCs; its discussion of cells derived from those sources concerns adrenal cells instead. No page number is available in our copy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 74 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ruiz-Babot, G., Hadjidemetriou, I., King, P. J., & Guasti, L.
Affiliations
Queen Mary University of London (GB)
Corresponding author
Guasti, Leonardo
Venue
Frontiers in Endocrinology
Published
2015-05-06
Volume
6
Pages
70-70
ISSN
1664-2392 (ISSN-L)
OpenAlex
W1533729004
Cited by
37
References
74
Citations by year
2024: 2 · 2023: 4 · 2022: 4 · 2021: 8 · 2020: 3 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 2
FWCI
0.55
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Endocrinology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
Funders
  • Rosetrees Trust
  • Directorate for Biological Sciences
  • Medical Research Council (G0802796, 608765)
  • Biotechnology and Biological Sciences Research Council (BB/L00267/1, BB/L002671/1)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
adrenal insufficiency, regenerative medicine, cell therapy, hypothalamic-pituitary-adrenal axis, corticosteroid replacement, stress response, adrenal disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review